Akebia Archives - International Biopharmaceutical Industry

Current Edition

Akebia to lay off 42% of workforce, suspend trials after FDA drug rejection

Dive Brief: Akebia Therapeutics will lay off 42% of its workforce after the Food and Drug Administration last month rejected its most advanced experimental drug, …

11 April 2022 Akebia Drug

Continue Reading →

Akebia

FDA rejects Akebia drug, dealing another blow to anemia pills

Dive Brief: The Food and Drug Administration rejected an Akebia Therapeutics’ anemia pill vadadustat, the company announced Wednesday, over concerns the drug isn’t as safe as currently …

1 April 2022 Akebia anemia

Continue Reading →

SEARCH

MENU

Current Edition

Upcoming Events

Advertisement

Akebia to lay off 42% of workforce, suspend trials after FDA drug rejection

FDA rejects Akebia drug, dealing another blow to anemia pills

International Biopharmaceutical Industry